Document:

EX-10.32

 Exhibit 10.32 

FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENT 

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of _______, 2022 by and between SeaStar
Medical Holding Corporation (the “Company”), and Eric Schlorff (“Executive”). 
 WHEREAS, SeaStar Medical, Inc.
and Executive previously entered into an Employment Agreement dated March 1, 2019, which was amended and restated on August 13, 2020 (“Prior Employment Agreement”); 

WHEREAS, SeaStar Medical, Inc. has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with LMF Acquisition
Opportunities, Inc. (“LMAO”), pursuant to which SeaStar Medical, Inc. expects to complete a business combination with LMAO and become a publicly traded company listed on NASDAQ Stock Market (the “SPAC Merger”); 

WHEREAS, upon completion of this SPAC Merger, SeaStar Medical, Inc. will become a wholly owned subsidiary of LMAO, and LMAO will be
renamed “SeaStar Medical Holding Corporation”; 
 WHEREAS, the Company and Executive now desire to amend the Prior
Employment Agreement to transfer Executive’s employment relationship from SeaStar Medical, Inc. to the Company, reflect changes to the Executive’s compensation, severance benefits, and to make certain other changes in connection with and
contingent upon the closing of the SPAC Merger; and 
 WHEREAS, this Agreement shall become effective as of and contingent upon the
closing of the SPAC Merger and supersedes and replaces all previous employment agreements or other written or oral agreements between Executive and either SeaStar Medical, Inc. or the Company, including the Prior Employment Agreement, with respect
to the subject matter covered under this Agreement. 
 NOW, THEREFORE, in consideration of the promises and mutual covenants
contained herein, the parties agree as follows: 
 1. Employment Period and Effective Date. The effective date
of this Agreement shall be the closing date of the SPAC Merger (the “Effective Date”). Following the Effective Date, Executive’s employment with the Company pursuant to this Agreement shall be “at will,” and either the
Company or Executive may terminate the employment relationship at any time in accordance with the provisions of Paragraph 7. The period during which Executive is in fact employed by the Company pursuant to this Agreement shall constitute the
“Employment Period” hereunder, and shall commence on the Effective Date. 
 2. Duties and Responsibilities. 

A. During the Employment Period, Executive shall serve as the Company’s Chief Executive Officer (“CEO”), with a principal
office in the Company’s Denver, Colorado location, subject to reasonable business travel, and shall report to the Board of Directors of the Company (the “Board”). Executive agrees to perform in good faith and to the best of his
ability all services that may be required of Executive hereunder and to be available to render such services at all reasonable times and places in accordance with such directions and requests as may be made from time to time by the Board. 

 

 B. Executive is expected and agrees to devote his full working time and attention to the
business of the Company, and will not render services to any other business without the prior approval of the Board, directly or indirectly, engage or participate in any business that is competitive in any manner with the business of the Company.
Notwithstanding the foregoing and subject to the approval of the Board, to continue to build executive presence, Executive may participate in up to two board of director roles (excluding the board of the Company) at one time, subject to any limits
or requirements of the Company’s corporate governance policies (as in effect from time to time)_and to the extent such service does not conflict or interfere with Executive’s duties to the Company. Executive also may invest in up to one
percent (1%) of the outstanding securities of any publicly-held corporation without approval of the Company, subject to any limits or requirements of the Company’s corporate governance policies (as in effect from time to time). Moreover, in the
sole discretion of, and upon approval from the , Executive may participate in other board or advisory positions that do not in any way negatively impact or conflict with the Company or Executive’s employment with the Company. The Executive
agrees that Executive shall disclose any such directorship to the Board prior to the Effective Time or prior to commencing any such position, as applicable. 

C. Executive understands and agrees that he must fully comply with the Company’s standard operating policies, procedures, and practices
that are from time to time in effect during the term of his employment. 
 3. Compensation. 

A. During the Employment Period, Executive shall receive an annual gross base salary in the amount of Four Hundred Twenty Thousand Dollars
($420,000), to be paid in periodic installments in accordance with the Company’s normal payroll procedures, less all applicable withholdings and deductions (“Base Salary”). 

B. During the Employment Period, Executive will be eligible to participate in an executive annual cash bonus plan, to the extent established
by the Compensation Committee of the Board (the “Compensation Committee”) from time to time for similarly-situated executives of the Company. The Executive’s participation in any such plan shall be governed by the terms and conditions
of such plan as then in effect and the decision to provide any bonus opportunity shall be in the sole and absolute discretion of the Compensation Committee. 

4. Equity. Following the Effective Date, subject to approval of the Board, the Company will grant Executive an
option under the Company’s equity incentive plan then in effect (the “Plan”) to purchase a number of shares of the Company’s Common Stock (the “Option”), which together with Executive’s existing equity in the
Company (including restricted stock units covering shares of Company Common Stock and options to purchase shares of Company Common Stock, in each case whether vested or unvested), will equal 1.5% of the issued and outstanding capital stock of the
Company, calculated on a fully-diluted basis, as of the Effective Date. The Option will have a per share exercise price equal to the fair market value of the Company’s common stock on the date of grant and will be immediately exercisable,
subject to the Company’s right of repurchase of unvested shares upon Executive’s termination of employment. 25% of the shares of common stock subject to the Option will vest upon the first anniversary of the Effective Date, and the
remaining 75% of such shares shall vest monthly in thirty six (36) equal monthly 

  
 2 

 
installments thereafter; vesting shall cease upon Executive’s cessation of employment with the Company. The Option will be subject to the terms and conditions of the Plan and the
written Stock Option Agreement governing the Option. Notwithstanding the foregoing (i) in the event of certain separations from service from the Company, the vesting of the Option will be accelerated to the extent set forth in Paragraph 8
below; and (ii) Executive shall have up to twelve (12) months following any termination of employment (other than termination for Cause (as defined below)) to exercise any then-vested outstanding options to purchase Company Common Stock
(and understands and assumes the burden for any modified tax treatment thereunder associated with the extended exercise period). 
 5.
Benefits; Reimbursement. 
 A. Health Insurance. During the Employment Period, Executive shall be eligible
to participate in all employee benefits and benefit plans generally made available to the Company’s employees from time-to-time, including, but not limited to,
medical, dental, vision and long-term disability insurance benefits and arrangements, subject to the terms, conditions and relevant qualification criteria for such benefits and benefit plans. The Company, in its discretion, may change from time-to-time the employee benefits and benefit plans it generally makes available to its employees. 

B. Expense Reimbursement. During the Employment Period, Executive shall be entitled to reimbursement for all reasonable
and necessary expenses incurred by Executive associated with the conduct of the Company’s business in accordance with the Company’s policies. Such reimbursements shall be subject to the Company’s then-existing policies and procedures
for reimbursement of business expenses, but in any event shall include submission of written requests for reimbursement within no more than thirty (30) days of incurring the expense, accompanied by vouchers, receipts or other details of such
expenses in the form required by the Company, sufficient to substantiate a deduction for such business expenses under all applicable rules and regulations of federal and state taxing authorities. If such expense qualifies for reimbursement, then the
Company will reimburse Executive for that expense in accordance with existing expense reimbursement policies and practices. 
 C.
Vacation, Sick, and Holiday Pay. During the Employment Period, Executive shall be entitled to earn or receive vacation, sick, and holiday pay pursuant to the terms of the Company’s generally applicable employee policies, as
may exist from time to time. 
 6. Proprietary Information and Inventions Agreement. As a condition of
employment and the benefits provided by this Agreement, Executive is required to timely execute and return the Company’s form of Proprietary Information and Inventions Agreement, attached hereto as Exhibit A (the
“PIIA”). Executive shall at all times remain subject to the terms and conditions of such PIIA, and nothing in this Agreement shall supersede, modify, or affect Executive’s obligations, duties, and responsibilities thereunder. 

7. Termination of Employment. Executive’s employment pursuant to this Agreement is “at will” and
may be terminated by either party at any time, with or without cause, in accordance with the following provisions: 
 A. Upon cessation of
Executive’s employment for any reason, Executive, or his estate if applicable, shall be paid any unpaid Base Salary earned under Paragraph 3 for services rendered through the date of such termination. 

  
 3 

 B. Executive may voluntarily separate from his employment under this Agreement at any time
and for any reasons, but shall give the Company at least thirty (30) days prior written notice of such resignation. 
 C. The Company
may terminate Executive’s employment with or without Cause under this Agreement at any time by providing notice of such termination to Executive. Such termination shall be effective immediately upon Executive’s receipt of such notice,
unless otherwise indicated by the notice. 
 8. Severance Benefits 

A. Resignation, Termination for Cause, or Death. If Executive resigns, is terminated for Cause (as defined below), or dies, then he (or
his estate, as applicable) shall only be entitled to payment of his Base Salary payable through the date of termination, but shall not otherwise be entitled to any severance or separation pay from the Company. 

B. Termination Without Cause. If the Company terminates Executive’s employment without Cause (as defined below) then, subject to
Executive timely executing, returning, and not revoking a separation agreement and general release of claims acceptable to the Company in its discretion (“Separation Agreement”), the Company will pay Executive as severance an amount
equivalent to twelve (12) months of Executive’s Base Salary in effect on the termination date (“Severance Payment”) and, subject to Executive timely and properly enrolling in continued health coverage under the Consolidated
Omnibus Budget Reconciliation Act (“COBRA”), an additional cash amount equal to the monthly premium cost of Executive’s coverage under the Company’s health plan, plus 2% of such amount (“Benefits Payment”), both payable
in equal installments as salary and benefits continuation payments for a twelve (12)-month period following the termination date (or, with respect to the Benefits Payment, such shorter period as described below) (“Severance Period”), in
accordance with the Company’s normal payroll dates and practices, the first installment of which shall be made on the Company’s first regular payroll period following the sixtieth (60th) day after the termination date (and will include any
Severance Payment and Benefits Payment installment(s) that would have otherwise been paid during the period following the termination date through the date of the first Severance Payment and Benefits Payment installment); provided that, Executive
has timely executed and delivered the Separation Agreement and the Separation Agreement has become irrevocable by its terms as of such date. Notwithstanding the foregoing, the Severance Payment shall be reduced by any amounts payable to Executive as
a result of any subsequent employment or service to another employer or service recipient other than the Company during the Severance Period and, if Executive obtains another employment or service arrangement prior to the end of the Severance Period
that offers Executive health coverage, then the Benefits Payment shall immediately cease as of such date Executive is eligible for such health coverage. Executive hereby agrees to notify the Company within five (5) business days of becoming
aware that Executive will begin employment or provide service to another employer or service recipient. Notwithstanding the foregoing, the Company reserves the right to restructure the Benefits Payment at any time and in any manner necessary to
comply with federal income tax law, as determined by the Company in its sole discretion. The Severance Payment and Benefits Payment shall be in lieu of any other severance benefits under any Company plan, program or policy, and Executive waives his
rights, if any, to have such payment taken into account in computing any other vested benefits payable to or on behalf of Executive, by the Company, if any. 

  
 4 

 C. Termination Without Cause Following Change in Control. If the Company terminates
Executive’s employment without Cause (as defined below) within twelve (12) months following a Change of Control (as defined below), then, in addition to the Severance Payment set forth above, and similarly subject to Executive timely
executing, returning, and not revoking the Separation Agreement, then 100% of any remaining balance of the Option shall immediately vest. 

(1) For purposes of this Agreement, “Cause” means, in the Company’s reasonable good faith belief that one of the following
have occurred: 
 (i) Executive’s commission of any act of fraud, embezzlement, dishonesty, or sexual harassment (or attempt to do any
of the foregoing); 
 (ii) Executive’s refusal or failure to comply in any material respect with any lawful direction of or written
policies or procedures of the Company, , or the Board (including, without limitation, the Company’s anti-discrimination and harassment policies and the Company’s drug and alcohol policy); 

(iii) any unauthorized use or disclosure by Executive of confidential information or trade secrets of the Company (or any parent or
subsidiary of the Company); or 
 (iv) any other gross negligence or misconduct by Executive adversely affecting the business or affairs of
the Company (or any parent or subsidiary of the Company) in a material manner. 
 (2) For purposes of this Agreement, “Change of
Control” means a change in ownership or control of the Company effected through any of the following transactions: 
 (i) a merger,
consolidation or other reorganization approved by the Company’s stockholders, unless securities representing fifty percent (50%) or more of the total combined voting power of the voting securities of the successor corporation are immediately
thereafter beneficially owned, directly or indirectly and in substantially the same proportion, by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction; 

(ii) a sale, transfer, or other disposition of all or substantially all of the Company’s assets; 

(iii) the closing of any transaction or series of related transactions pursuant to which any person or any group of persons comprising a
“group” within the meaning of Rule 13d-5(b)(1) of the Securities Exchange Act of 1934, as amended (the “1934 Act”) (other than the Company or a person that, prior to such transaction or
series of related transactions, directly or indirectly controls, is controlled by or is under common control with, the Company) acquires directly or indirectly (whether as a result of a single acquisition or by reason of one or more acquisitions
within the twelve (12)-month period ending with the most recent acquisition) beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing (or convertible into or exercisable
for securities possessing) fifty percent (50%) or more of the total combined voting power of the Company’s securities (as measured in terms of the power to vote with respect to the election of Board members) outstanding immediately after the
consummation of such transaction or series of related transactions, whether such transaction involves a direct issuance from the Company or the acquisition of outstanding securities held by one or more of the Company’s existing stockholders; or

  
 5 

 (iv) a change in the composition of the Board over a period of twelve (12) consecutive
months or less such that a majority of the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such
period or (B) have been elected or nominated for election as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the time the Board approved such election or
nomination. 
 9. Benefit Limit. The benefit limitations of this Paragraph shall be applicable in the event
Executive receives any benefits under this Agreement that are deemed to constitute parachute payments under Code Section 280G. In the event that any payments to which Executive becomes entitled in accordance with the provisions of this
Agreement would otherwise constitute a parachute payment under Code Section 280G, then such payments will be subject to reduction to the extent necessary to assure that Executive receives only the greater of (i) the amount of those
payments which would not constitute such a parachute payment or (ii) the amount which yields Executive the greatest after-tax amount of benefits after taking into account any excise tax imposed on the
payments provided to Executive under this Agreement (or on any other benefits to which Executive may become entitled in connection with any change in control or ownership of the Company or the subsequent termination of his employment with the
Company) under Code Section 4999. 
 10. Delayed Commencement of Benefits. Notwithstanding any provision to
the contrary in this Agreement, no payments or benefits that are subject to the restrictions of Code Section 409A to which Executive becomes entitled under this Agreement shall be made or paid to Executive prior to the earlier of
(i) the expiration of the six (6)-month period measured from the date of his separation from service with the Company or (ii) the date of his death, if Executive is deemed at the time of such separation from service a “key
employee” within the meaning of that term under Code Section 416(i) and such delayed commencement is otherwise required in order to avoid a prohibited distribution under Code Section 409A(a)(2). Upon the expiration of the applicable
Code Section 409A(a)(2) deferral period, all payments deferred pursuant to this Paragraph shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid in accordance with the normal payment dates
specified for them herein. 
 11. Compliance with Section 409A. It is the
intent of the Company and Executive that the provisions of this Agreement comply with all applicable requirements of Code Section 409A. Accordingly, to the extent any provisions of this Agreement would otherwise contravene one or more
requirements or limitations of Code Section 409A, then the Company and Executive shall, within the remedial amendment period provided under the Treasury Regulations issued under Code Section 409A, effect through mutual agreement the
appropriate amendments to those provisions which are necessary in order to bring the provisions of this Agreement into compliance with Code Section 409A. If any payment under this Agreement is subject to Code Section 409A,
(i) distributions shall only be made in a manner and upon an event permitted under Code Section 409A, (ii) payments to be made upon a termination of employment or service shall only be made upon a “separation from service”
under Code Section 409A, (iii) each installment of a payment shall be treated as a separate payment for purposes of Code Section 409A, (iv) if any payment is subject to the execution of a Separation Agreement, in no event shall
the timing of Executive’s 

  
 6 

 
execution of the Separation Agreement result in Executive designating, directly or indirectly, the calendar year of payment, and if such a payment that is subject to execution of the Separation
Agreement could be made in more than one taxable year, payment shall be made in the later taxable year, and (v) any reimbursements of costs and expenses or in-kind benefits shall be made on or before the
last calendar day of the year following the calendar year in which the expense occurred, unless otherwise permitted by Section 409A. 

12. Cessation of Benefits. In the event of a breach by Executive of any of his obligations of this Agreement or
under the PIIA, he shall cease to be entitled to any further benefits under this Agreement. In no event shall Executive be entitled to any severance benefits under this Agreement if (i) his employment ceases by reason of a termination for
Cause, or (ii) he voluntarily resigns from employment with the Company. 
 13. Successors and Assigns. This
Agreement and all rights hereunder are personal to Executive and may not be transferred or assigned by Executive at any time. The Company may assign its rights, together with its obligations hereunder, to any parent, subsidiary, affiliate, or
successor, or in connection with any sale, transfer, or other disposition of all or substantially all of its business and assets, provided, however, that any such assignee assumes the Company’s obligations hereunder. 

14. Notices. 
 A.
Any and all notices, demands or other communications required or desired to be given hereunder by any party shall be in writing and shall be validly given or made to another party if delivered either personally or if deposited in the United States
mail, certified or registered, postage prepaid, return receipt requested. If such notice, demand, or other communication shall be delivered personally, then such notice shall be conclusively deemed given at the time of such personal delivery. 

B. If such notice, demand, or other communication is given by mail, such notice shall be conclusively deemed given forty-eight (48) hours
after deposit in the United States mail addressed to the party to whom such notice, demand or other communication is to be given as hereinafter set forth: 

To the Company: 
 SeaStar
Medical Holding Corporation 
 3513 Brighton Blvd 

Ste 410 
 Denver, CO 80516 

Attn: Rick Barnett, Chair of Compensation Committee 

To Executive: 
 Eric
Schlorff 
 [            ] 

  
 7 

 C. Any party hereto may change its address for the purpose of receiving notices, demands and
other communications as herein provided by a written notice given in the manner aforesaid to the other party hereto. 
 15.
General Creditor Status. The benefits to which Executive may become entitled under this Agreement shall be paid, when due, from the Company’s general assets, and no trust fund, escrow arrangement or other segregated
account shall be established as a funding vehicle for such payments. Accordingly, Executive’s right (or the right of the executors or administrators of Executive’s estate) to receive such benefits shall at all times be that of a general
creditor of the Company and shall have no priority over the claims of other general creditors. 
 16. Governing
Documents. This Agreement, together with (i) any equity award agreements, and (ii) the PIIA, shall constitute the entire agreement and understanding of the Company and Executive with respect to the terms and conditions of
Executive’s employment with the Company and the eligibility for any potential severance payments and consulting payments following separation from employment with the Company, and this Agreement shall supersede all prior and contemporaneous
written or verbal agreements and understandings between Executive and SeaStar Medical, Inc. or the Company relating to such subject matter, including, without limitation, the Prior Agreement. This Agreement, including but not limited to the at-will nature of the employment relationship as reflected herein, may only be amended by written instrument signed by Executive and the chairman of the Board. 

17. Governing Law. The provisions of Agreement shall be construed and interpreted under the laws of the State of
Colorado applicable to agreements executed and wholly performed within the State of Colorado. If any provision of this Agreement as applied to any party or to any circumstance should be adjudged by a court of competent jurisdiction to be void or
unenforceable for any reason, the invalidity of that provision shall in no way affect (to the maximum extent permissible by law) the application of such provision under circumstances different from those adjudicated by the court, the application of
any other provision of this Agreement, or the enforceability or invalidity of this Agreement as a whole. Should any provision of this Agreement become or be deemed invalid, illegal or unenforceable in any jurisdiction by reason of the scope, extent
or duration of its coverage, then such provision shall be deemed amended to the extent necessary to conform to applicable law so as to be valid and enforceable or, if such provision cannot be so amended without materially altering the intention of
the parties, then such provision will be stricken, and the remainder of this Agreement shall continue in full force and effect. 
 18.
Arbitration. 
 A. Except as provided herein and the PIIA, each party hereto agrees that any and all disputes which arise out of
or relate to Executive’s employment, the termination of Executive’s employment, or the terms of this Agreement shall be resolved through final and binding arbitration. Such arbitration shall be in lieu of any trial before a judge and/or
jury, and Executive and the Company expressly waive all rights to have such disputes resolved via trial before a judge and/or jury. Such disputes shall include, without limitation, claims for breach of contract or of the covenant of good faith and
fair dealing, claims of discrimination, claims under any federal, state, or local law or regulation now in existence or hereinafter enacted and as amended from time to time concerning in any way Executive’s employment with the Company or its
termination. The only claims not covered by this Employment Agreement to arbitrate disputes, which shall instead be resolved pursuant to applicable law, are: (i) claims for benefits under the unemployment insurance benefits; (ii) claims
for workers’ compensation benefits under any of the Company’s workers’ compensation insurance policy or fund; (iii) claims under the National Labor Relations Act; and (iv) claims that may not be arbitrated as a matter of
law. 

  
 8 

 B. Arbitration will be conducted in Colorado. Arbitration shall be conducted in accordance
with the Federal Arbitration Act (“FAA”) and the National Rules for the Resolution of Employment Disputes of the American Arbitration Association (“AAA Rules” available at www.adr.org) or any other discovery required by
applicable law in arbitration proceedings, including, but not limited to, discovery available under the applicable state and/or federal arbitration statutes. Also, to the extent that any of the AAA Rules or anything in this arbitration section
conflicts with any arbitration procedures required by applicable law, the arbitration procedures required by applicable law shall govern. 

C. During the course of arbitration, the Company will bear the cost of (i) the arbitrator’s fee, and (ii) any other expense or
cost Executive would not be required to bear if Executive were free to bring the dispute or claim in court. Each party shall bear such party’s own attorneys’ fees incurred in connection with the arbitration. The arbitrator will not have
authority to award attorneys’ fees unless a statute or contract at issue in the dispute authorizes the award of attorneys’ fees to the prevailing party. In such case, the arbitrator shall have the authority to make an award of
attorneys’ fees as required or permitted by the applicable statute or contract. 
 D. The arbitrator shall issue a written award that
sets forth the essential findings of fact and conclusions of law on which the award is based. The arbitrator shall have the authority to award any relief authorized by law in connection with the asserted claims or disputes. The arbitrator’s
award shall be subject to correction, confirmation, or vacation, as provided by applicable law setting forth the standard of judicial review of arbitration awards. Judgment upon the arbitrator’s award may be entered in any court having
jurisdiction thereof. 
 E. This arbitration provision does not prohibit Executive from pursuing an administrative claim with a local,
state, or federal administrative agency such as the Equal Employment Opportunity Commission, but this arbitration agreement does prohibit Executive from seeking or pursuing court action regarding any such claim. 

19. Counterparts. This Agreement may be executed in more than one counterpart, each of which shall be deemed an
original, but all of which together shall constitute but one and the same instrument. 
 20. Construction. The
language of this Agreement shall be construed as to its fair meaning, and not strictly for or against either party. Any rule of construction that any ambiguities in a contract shall be construed against the drafter of a contract shall not apply.

 21. Indemnification. Executive will be provided indemnification to the maximum extent permitted by the
Company’s and its subsidiaries’ and affiliates’ Articles of Incorporation or Bylaws, but on terms no less favorable than provided to any other Company executive officer or director and subject to the terms of any separate written
indemnification agreement. 
 [Signature Page Follows] 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day and year
written above. 
  

	
	SEASTAR MEDICAL HOLDING CORPORATION
	
	By:                                     
                                         
                  
	
	Title:                                     
                                         
              
	
	EXECUTIVE
	
	  

	Eric Schlorff

  
 10EX-10.33

 Exhibit 10.33 

FORM OF AMENDED AND RESTATED EMPLOYMENT AGREEMENT 

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is made as of _______, 2022 by and between SeaStar
Medical Holding Corporation (the “Company”), and Caryl Baron (“Executive”). 
 WHEREAS, SeaStar Medical, Inc. and
Executive previously entered into an employment agreement dated March 22, 2020 (“Prior Employment Agreement”); 

WHEREAS, SeaStar Medical, Inc. has entered into an Agreement and Plan of Merger (the “Merger Agreement”) with LMF Acquisition
Opportunities, Inc. (“LMAO”), pursuant to which SeaStar Medical, Inc. expects to complete a business combination with LMAO and become a publicly traded company listed on NASDAQ Stock Market (the “SPAC Merger”); 

WHEREAS, upon completion of this SPAC Merger, SeaStar Medical, Inc. will become a wholly owned subsidiary of LMAO, and LMAO will be
renamed “SeaStar Medical Holding Corporation;” 
 WHEREAS, the Company and Executive now desire to amend the Prior
Employment Agreement to transfer Executive’s employment relationship from SeaStar Medical, Inc. to the Company, reflect changes to the Executive’s compensation, severance benefits, and to make certain other changes in connection with and
contingent upon the closing of the SPAC Merger; and 
 WHEREAS, this Agreement shall become effective as of and contingent upon the
closing of the SPAC Merger and supersedes and replaces all previous employment agreements or other written or oral agreements between Executive and either SeaStar Medical, Inc. or the Company, including the Prior Employment Agreement, with respect
to the subject matter covered under this Agreement. 
 NOW, THEREFORE, in consideration of the promises and mutual covenants
contained herein, the parties agree as follows: 
 1. Employment Period and Effective Date. The effective date
of this Agreement shall be the closing date of the SPAC Merger (the “Effective Date”). Following the Effective Date, Executive’s employment with the Company pursuant to this Agreement shall be “at will,” and either the
Company or Executive may terminate the employment relationship at any time in accordance with the provisions of Paragraph 7. The period during which Executive is in fact employed by the Company pursuant to this Agreement shall constitute the
“Employment Period” hereunder, and shall commence on the Effective Date. 
 2. Duties and Responsibilities. 

A. During the Employment Period, Executive shall serve as the Company’s Finance Controller (“Finance Controller”), with a
principal office in the Company’s Denver, Colorado location, subject to reasonable business travel, and shall report to the Company’s Chief Executive Officer (“CEO”). Executive agrees to perform in good faith and to the best of
her ability all services that may be required of Executive hereunder and to be available to render such services at all reasonable times and places in accordance with such directions and requests as may be made from time to time by the Company or
Board of Directors of the Company (the “Board”). 

 B. Executive is expected and agrees to devote her full working time and attention to the
business of the Company, and will not render services to any other business without the prior approval of the Board, directly or indirectly, engage or participate in any business that is competitive in any manner with the business of the Company.
Executive may invest in up to one percent (1%) of the outstanding securities of any publicly-held corporation without approval of the Company, subject to any limits or requirements of the Company’s corporate governance policies (as in effect
from time to time). Moreover, in the sole discretion of, and upon approval from, the CEO, Executive may participate in other board or advisory positions that do not in any way negatively impact or conflict with the Company or Executive’s
employment with the Company. The Executive agrees that Executive shall disclose any such directorship to the Board prior to the Effective Time or prior to commencing any such position, as applicable. 

C. Executive understands and agrees that she must fully comply with the Company’s standard operating policies, procedures, and practices
that are from time to time in effect during the term of her employment. 
 3. Compensation. 

A. During the Employment Period, Executive shall receive an annual gross base salary in the amount of Two Hundred Ten Thousand Dollars
($210,000), to be paid in periodic installments in accordance with the Company’s normal payroll procedures, less all applicable withholdings and deductions (“Base Salary”). 

B. During the Employment Period, Executive will be eligible to participate in an executive annual cash bonus plan to the extent established by
the Compensation Committee of the Board (the “Compensation Committee”) from time to time for similarly-situated executives of the Company. The Executive’s participation in any such plan shall be governed by the terms and conditions of
such plan as then in effect and the decision to provide any bonus opportunity shall be in the sole and absolute discretion of the Compensation Committee. 

4. Equity. Following the Effective Date, subject to approval of the Board, the Company will grant Executive an
option under the Company’s equity incentive plan then in effect (the “Plan”) to purchase a number of shares of the Company’s Common Stock (the “Option”), which together with Executive’s existing equity in the
Company (including restricted stock units covering shares of Company Common Stock and options to purchase shares of Company Common Stock, in each case whether vested or unvested), will equal 0.25% of the issued and outstanding capital stock of the
Company, calculated on a fully-diluted basis, as of the Effective Date. The Option will have a per share exercise price equal to the fair market value of the Company’s common stock on the date of grant and will be immediately exercisable,
subject to the Company’s right of repurchase of unvested shares upon Executive’s termination of employment. 25% of the shares of common stock subject to the Option will vest upon the first anniversary of the Effective Date, and the
remaining 75% of such shares shall vest monthly in thirty six (36) equal monthly installments thereafter; vesting shall cease upon Executive’s cessation of employment with the Company. The Option will be subject to the terms and
conditions of the Plan and the written Stock Option Agreement governing the Option. Notwithstanding the foregoing (i) in the event of certain separations from service from the Company, the vesting of the Option will be accelerated to the extent
set forth in Paragraph 8 below; and (ii) Executive shall have up to twelve (12) months following any termination of employment (other than termination for Cause (as defined below)) to exercise any then-vested outstanding options to
purchase Company Common Stock (and understands and assumes the burden for any modified tax treatment thereunder associated with the extended exercise period). 

  
 2 

 5. Benefits; Reimbursement. 

A. Health Insurance. During the Employment Period, Executive shall be eligible to participate in all employee benefits
and benefit plans generally made available to the Company’s employees from time-to-time, including, but not limited to, medical, dental, vision and long-term
disability insurance benefits and arrangements, subject to the terms, conditions and relevant qualification criteria for such benefits and benefit plans. The Company, in its discretion, may change from time-to-time the employee benefits and benefit plans it generally makes available to its employees. 

B. Expense Reimbursement. During the Employment Period, Executive shall be entitled to reimbursement for all reasonable
and necessary expenses incurred by Executive associated with the conduct of the Company’s business in accordance with the Company’s policies. Such reimbursements shall be subject to the Company’s then-existing policies and procedures
for reimbursement of business expenses, but in any event shall include submission of written requests for reimbursement within no more than thirty (30) days of incurring the expense, accompanied by vouchers, receipts or other details of such
expenses in the form required by the Company, sufficient to substantiate a deduction for such business expenses under all applicable rules and regulations of federal and state taxing authorities. If such expense qualifies for reimbursement, then the
Company will reimburse Executive for that expense in accordance with existing expense reimbursement policies and practices. 
 C.
Vacation, Sick, and Holiday Pay. During the Employment Period, Executive shall be entitled to earn or receive vacation, sick, and holiday pay pursuant to the terms of the Company’s generally applicable employee policies, as
may exist from time to time. 
 6. Proprietary Information and Inventions Agreement. As a condition of
employment and the benefits provided by this Agreement, Executive is required to timely execute and return the Company’s form of Proprietary Information and Inventions Agreement, attached hereto as Exhibit A (the
“PIIA”). Executive shall at all times remain subject to the terms and conditions of such PIIA, and nothing in this Agreement shall supersede, modify, or affect Executive’s obligations, duties, and responsibilities thereunder. 

7. Termination of Employment. Executive’s employment pursuant to this Agreement is “at will” and
may be terminated by either party at any time, with or without cause, in accordance with the following provisions: 
 A. Upon cessation of
Executive’s employment for any reason, Executive, or his estate if applicable, shall be paid any unpaid Base Salary earned under Paragraph 3 for services rendered through the date of such termination. 

B. Executive may voluntarily separate from her employment under this Agreement at any time and for any reasons, but shall give the Company at
least thirty (30) days prior written notice of such resignation. 
 C. The Company may terminate Executive’s employment with or
without Cause under this Agreement at any time by providing notice of such termination to Executive. Such termination shall be effective immediately upon Executive’s receipt of such notice, unless otherwise indicated by the notice. 

  
 3 

 8. Severance Benefits 

A. Resignation, Termination for Cause, or Death. If Executive resigns, is terminated for Cause (as defined below), or dies, then she
(or her estate, as applicable) shall only be entitled to payment of her Base Salary payable through the date of termination, but shall not otherwise be entitled to any severance or separation pay from the Company. 

B. Termination Without Cause. If the Company terminates Executive’s employment without Cause (as defined below) then, subject to
Executive timely executing, returning, and not revoking a separation agreement and general release of claims acceptable to the Company in its discretion (“Separation Agreement”), the Company will pay Executive as severance an amount
equivalent to nine (9) months of Executive’s Base Salary in effect on the termination date (“Severance Payment”) and, subject to Executive timely and properly enrolling in continued health coverage under the Consolidated Omnibus
Budget Reconciliation Act (“COBRA”), an additional cash amount equal to the monthly premium cost of Executive’s coverage under the Company’s health plan, plus 2% of such amount (“Benefits Payment”), both payable in
equal installments as salary continuation payments for a nine (9)-month period following the termination date (or, with respect to the Benefits Payment, such shorter period as described below) (“Severance Period”), in accordance with the
Company’s normal payroll dates and practices, the first installment of which shall be made on the Company’s first regular payroll period following the sixtieth (60th) day after the termination date (and will include any Severance Payment
and Benefits Payment installment(s) that would have otherwise been paid during the period following the termination date through the date of the first Severance Payment and Benefits Payment installment); provided that, Executive has timely executed
and delivered the Separation Agreement and the Separation Agreement has become irrevocable by its terms as of such date. Notwithstanding the foregoing, the Severance Payment shall be reduced by any amounts payable to Executive as a result of any
subsequent employment or service to another employer or service recipient other than the Company during the Severance Period and, if Executive obtains another employment or service arrangement prior to the end of the Severance Period that offers
Executive health coverage, then the Benefits Payment shall immediately cease as of such date Executive is eligible for such health coverage. Executive hereby agrees to notify the Company within five (5) business days of becoming aware that
Executive will begin employment or provide service to another employer or service recipient. Notwithstanding the foregoing, the Company reserves the right to restructure the Benefits Payment at any time and in any manner necessary to comply with
federal income tax law, as determined by the Company in its sole discretion. The Severance Payment and Benefits Payment shall be in lieu of any other severance benefits under any Company plan, program or policy, and Executive waives her rights, if
any, to have such payment taken into account in computing any other vested benefits payable to or on behalf of Executive, by the Company, if any. 

C. Termination Without Cause Following Change in Control. If the Company terminates Executive’s employment without Cause (as
defined below) within twelve (12) months following a Change of Control (as defined below), then, in addition to the Severance Payment set forth above, and similarly subject to Executive timely executing, returning, and not revoking the
Separation Agreement, then 100% of any remaining balance of the Option shall immediately vest. 

  
 4 

 (1) For purposes of this Agreement, “Cause” means, in the Company’s
reasonable good faith belief that one of the following have occurred: 
 (i) Executive’s commission of any act of fraud, embezzlement,
dishonesty, or sexual harassment (or attempt to do any of the foregoing); 
 (ii) Executive’s refusal or failure to comply in any
material respect with any lawful direction of or written policies or procedures of the Company, or the Board (including, without limitation, the Company’s anti-discrimination and harassment policies and the Company’s drug and alcohol
policy); 
 (iii) any unauthorized use or disclosure by Executive of confidential information or trade secrets of the Company (or any
parent or subsidiary of the Company); or 
 (iv) any other gross negligence or misconduct by Executive adversely affecting the business or
affairs of the Company (or any parent or subsidiary of the Company) in a material manner. 
 (v) 

(2) For purposes of this Agreement, “Change of Control” means a change in ownership or control of the Company effected through any
of the following transactions: 
 (i) a merger, consolidation or other reorganization approved by the Company’s stockholders, unless
securities representing fifty percent (50%) or more of the total combined voting power of the voting securities of the successor corporation are immediately thereafter beneficially owned, directly or indirectly and in substantially the same
proportion, by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction; 

(ii) a sale, transfer, or other disposition of all or substantially all of the Company’s assets; 

(iii) the closing of any transaction or series of related transactions pursuant to which any person or any group of persons comprising a
“group” within the meaning of Rule 13d-5(b)(1) of the Securities Exchange Act of 1934, as amended (the “1934 Act”) (other than the Company or a person that, prior to such transaction or
series of related transactions, directly or indirectly controls, is controlled by or is under common control with, the Company) acquires directly or indirectly (whether as a result of a single acquisition or by reason of one or more acquisitions
within the twelve (12)-month period ending with the most recent acquisition) beneficial ownership (within the meaning of Rule 13d-3 of the 1934 Act) of securities possessing (or convertible into or exercisable
for securities possessing) fifty percent (50%) or more of the total combined voting power of the Company’s securities (as measured in terms of the power to vote with respect to the election of Board members) outstanding immediately after the
consummation of such transaction or series of related transactions, whether such transaction involves a direct issuance from the Company or the acquisition of outstanding securities held by one or more of the Company’s existing stockholders; or

  
 5 

 (iv) a change in the composition of the Board over a period of twelve (12) consecutive
months or less such that a majority of the Board members ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who either (A) have been Board members continuously since the beginning of such
period or (B) have been elected or nominated for election as Board members during such period by at least a majority of the Board members described in clause (A) who were still in office at the time the Board approved such election or
nomination. 
 9. Benefit Limit. The benefit limitations of this Paragraph shall be applicable in the event
Executive receives any benefits under this Agreement that are deemed to constitute parachute payments under Code Section 280G. In the event that any payments to which Executive becomes entitled in accordance with the provisions of this
Agreement would otherwise constitute a parachute payment under Code Section 280G, then such payments will be subject to reduction to the extent necessary to assure that Executive receives only the greater of (i) the amount of those
payments which would not constitute such a parachute payment or (ii) the amount which yields Executive the greatest after-tax amount of benefits after taking into account any excise tax imposed on the
payments provided to Executive under this Agreement (or on any other benefits to which Executive may become entitled in connection with any change in control or ownership of the Company or the subsequent termination of her employment with the
Company) under Code Section 4999. 
 10. Delayed Commencement of Benefits. Notwithstanding any provision to
the contrary in this Agreement, no payments or benefits that are subject to the restrictions of Code Section 409A to which Executive becomes entitled under this Agreement shall be made or paid to Executive prior to the earlier of
(i) the expiration of the six (6)-month period measured from the date of her separation from service with the Company or (ii) the date of her death, if Executive is deemed at the time of such separation from service a “key
employee” within the meaning of that term under Code Section 416(i) and such delayed commencement is otherwise required in order to avoid a prohibited distribution under Code Section 409A(a)(2). Upon the expiration of the applicable
Code Section 409A(a)(2) deferral period, all payments deferred pursuant to this Paragraph shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid in accordance with the normal payment dates
specified for them herein. 
 11. Compliance with Section 409A. It is the
intent of the Company and Executive that the provisions of this Agreement comply with all applicable requirements of Code Section 409A. Accordingly, to the extent any provisions of this Agreement would otherwise contravene one or more
requirements or limitations of Code Section 409A, then the Company and Executive shall, within the remedial amendment period provided under the Treasury Regulations issued under Code Section 409A, effect through mutual agreement the
appropriate amendments to those provisions which are necessary in order to bring the provisions of this Agreement into compliance with Code Section 409A. If any payment under this Agreement is subject to Code Section 409A,
(i) distributions shall only be made in a manner and upon an event permitted under Code Section 409A, (ii) payments to be made upon a termination of employment or service shall only be made upon a “separation from service”
under Code Section 409A, (iii) each installment of a payment shall be treated as a separate payment for purposes of Code Section 409A, (iv) if any payment is subject to the execution of a Separation Agreement, in no event shall
the timing of Executive’s execution of the Separation Agreement result in Executive designating, directly or indirectly, the calendar year of payment, and if such a payment that is subject to execution of the Separation Agreement could be made
in more than one taxable year, payment shall be made in the later taxable year, and (v) any reimbursements of costs and expenses or in-kind benefits shall be made on or before the last calendar day of the
year following the calendar year in which the expense occurred, unless otherwise permitted by Section 409A. 

  
 6 

 12. Cessation of Benefits. In the event of a breach by Executive
of any of her obligations of this Agreement or under the PIIA, she shall cease to be entitled to any further benefits under this Agreement. In no event shall Executive be entitled to any severance benefits under this Agreement if (i) her
employment ceases by reason of a termination for Cause, or (ii) she voluntarily resigns from employment with the Company. 
 13.
Successors and Assigns. This Agreement and all rights hereunder are personal to Executive and may not be transferred or assigned by Executive at any time. The Company may assign its rights, together with its obligations
hereunder, to any parent, subsidiary, affiliate, or successor, or in connection with any sale, transfer, or other disposition of all or substantially all of its business and assets, provided, however, that any such assignee assumes the
Company’s obligations hereunder. 
 14. Notices. 

A. Any and all notices, demands or other communications required or desired to be given hereunder by any party shall be in writing and shall
be validly given or made to another party if delivered either personally or if deposited in the United States mail, certified or registered, postage prepaid, return receipt requested. If such notice, demand, or other communication shall be delivered
personally, then such notice shall be conclusively deemed given at the time of such personal delivery. 
 B. If such notice, demand, or
other communication is given by mail, such notice shall be conclusively deemed given forty-eight (48) hours after deposit in the United States mail addressed to the party to whom such notice, demand or other communication is to be given as
hereinafter set forth: 
 To the Company: 

SeaStar Medical Holding Corporation 

3513 Brighton Blvd 
 Ste 410

 Denver, CO 80516 
 Attn:
Chief Executive Officer 
 To Executive: 

Caryl Baron 

[                ] 

C. Any party hereto may change its address for the purpose of receiving notices, demands and other communications as herein provided by a
written notice given in the manner aforesaid to the other party hereto. 

  
 7 

 15. General Creditor Status. The benefits to which Executive may
become entitled under this Agreement shall be paid, when due, from the Company’s general assets, and no trust fund, escrow arrangement or other segregated account shall be established as a funding vehicle for such payments. Accordingly,
Executive’s right (or the right of the executors or administrators of Executive’s estate) to receive such benefits shall at all times be that of a general creditor of the Company and shall have no priority over the claims of other general
creditors. 
 16. Governing Documents. This Agreement, together with (i) any equity award agreements, and
(ii) the PIIA, shall constitute the entire agreement and understanding of the Company and Executive with respect to the terms and conditions of Executive’s employment with the Company and the eligibility for any potential severance
payments and consulting payments following separation from employment with the Company, and this Agreement shall supersede all prior and contemporaneous written or verbal agreements and understandings between Executive and SeaStar Medical, Inc. or
the Company relating to such subject matter, including, without limitation, the Prior Agreement. This Agreement, including but not limited to the at-will nature of the employment relationship as reflected
herein, may only be amended by written instrument signed by Executive and the CEO. 
 17. Governing Law. The
provisions of Agreement shall be construed and interpreted under the laws of the State of Colorado applicable to agreements executed and wholly performed within the State of Colorado. If any provision of this Agreement as applied to any party or to
any circumstance should be adjudged by a court of competent jurisdiction to be void or unenforceable for any reason, the invalidity of that provision shall in no way affect (to the maximum extent permissible by law) the application of such provision
under circumstances different from those adjudicated by the court, the application of any other provision of this Agreement, or the enforceability or invalidity of this Agreement as a whole. Should any provision of this Agreement become or be deemed
invalid, illegal or unenforceable in any jurisdiction by reason of the scope, extent or duration of its coverage, then such provision shall be deemed amended to the extent necessary to conform to applicable law so as to be valid and enforceable or,
if such provision cannot be so amended without materially altering the intention of the parties, then such provision will be stricken, and the remainder of this Agreement shall continue in full force and effect. 

18. Arbitration. 

A. Except as provided herein and the PIIA, each party hereto agrees that any and all disputes which arise out of or relate to Executive’s
employment, the termination of Executive’s employment, or the terms of this Agreement shall be resolved through final and binding arbitration. Such arbitration shall be in lieu of any trial before a judge and/or jury, and Executive and the
Company expressly waive all rights to have such disputes resolved via trial before a judge and/or jury. Such disputes shall include, without limitation, claims for breach of contract or of the covenant of good faith and fair dealing, claims of
discrimination, claims under any federal, state, or local law or regulation now in existence or hereinafter enacted and as amended from time to time concerning in any way Executive’s employment with the Company or its termination. The only
claims not covered by this Employment Agreement to arbitrate disputes, which shall instead be resolved pursuant to applicable law, are: (i) claims for benefits under the unemployment insurance benefits; (ii) claims for workers’
compensation benefits under any of the Company’s workers’ compensation insurance policy or fund; (iii) claims under the National Labor Relations Act; and (iv) claims that may not be arbitrated as a matter of law. 

  
 8 

 B. Arbitration will be conducted in Colorado. Arbitration shall be conducted in accordance
with the Federal Arbitration Act (“FAA”) and the National Rules for the Resolution of Employment Disputes of the American Arbitration Association (“AAA Rules” available at www.adr.org) or any other discovery required by
applicable law in arbitration proceedings, including, but not limited to, discovery available under the applicable state and/or federal arbitration statutes. Also, to the extent that any of the AAA Rules or anything in this arbitration section
conflicts with any arbitration procedures required by applicable law, the arbitration procedures required by applicable law shall govern. 

C. During the course of arbitration, the Company will bear the cost of (i) the arbitrator’s fee, and (ii) any other expense or
cost Executive would not be required to bear if Executive were free to bring the dispute or claim in court. Each party shall bear such party’s own attorneys’ fees incurred in connection with the arbitration. The arbitrator will not have
authority to award attorneys’ fees unless a statute or contract at issue in the dispute authorizes the award of attorneys’ fees to the prevailing party. In such case, the arbitrator shall have the authority to make an award of
attorneys’ fees as required or permitted by the applicable statute or contract. 
 D. The arbitrator shall issue a written award that
sets forth the essential findings of fact and conclusions of law on which the award is based. The arbitrator shall have the authority to award any relief authorized by law in connection with the asserted claims or disputes. The arbitrator’s
award shall be subject to correction, confirmation, or vacation, as provided by applicable law setting forth the standard of judicial review of arbitration awards. Judgment upon the arbitrator’s award may be entered in any court having
jurisdiction thereof. 
 E. This arbitration provision does not prohibit Executive from pursuing an administrative claim with a local,
state, or federal administrative agency such as the Equal Employment Opportunity Commission, but this arbitration agreement does prohibit Executive from seeking or pursuing court action regarding any such claim. 

19. Counterparts. This Agreement may be executed in more than one counterpart, each of which shall be deemed an
original, but all of which together shall constitute but one and the same instrument. 
 20. Construction. The
language of this Agreement shall be construed as to its fair meaning, and not strictly for or against either party. Any rule of construction that any ambiguities in a contract shall be construed against the drafter of a contract shall not apply.

 21. Indemnification. Executive will be provided indemnification to the maximum extent permitted by the
Company’s and its subsidiaries’ and affiliates’ Articles of Incorporation or Bylaws, but on terms no less favorable than provided to any other Company executive officer or director and subject to the terms of any separate written
indemnification agreement. 
 [SIGNATURE PAGE FOLLOWS] 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day and year
written above. 
  

			
	SEASTAR MEDICAL HOLDING CORPORATION
		
	By:	 	  

		
	Title:	 	  

	
	EXECUTIVE
	
	  

	
	Caryl Baron

  

  
 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]